Induction chemotherapy with cisplatin, bleomycin and methotrexate in advanced head and neck cancer—lack of therapeutic gain
✍ Scribed by Villar, A.; Pera, J.; Arellano, A.; Galiana, R.; Villá, S.; Farrus, B.; Hernandez, M.
- Book ID
- 122023986
- Publisher
- Elsevier Science
- Year
- 1987
- Tongue
- English
- Weight
- 414 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0167-8140
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Thirty-one patients with Stage III-IV head and neck squamous cell cancer were treated by three courses of combination chemotherapy using bleomycin, methotrexate, and cisplatin followed by a radical course of radiation and in two cases by surgery. Of 29 evaluable patients, 4 (14%) achieved complete r
One hundred ninety-one patients with recurrent or metastatic squamous cell carcinoma of head and neck origin were allocated at random to chemotherapy with conventional-dose weekly intravenous methotrexate or the combination of cisplatin, vinblastine, and bleomycin. Methotrexate induced responses in